Form 8-K. Sally Beauty Holdings, Inc. - SBH. Filed: December 19, 2006 (period: December 19, 2006)

Size: px
Start display at page:

Download "Form 8-K. Sally Beauty Holdings, Inc. - SBH. Filed: December 19, 2006 (period: December 19, 2006)"

Transcription

1 THE FOLLOWING INFORMATION, DOCUMENT OR REPORT IS BEING MADE AVAILABLE BY SALLY HOLDINGS LLC TO THE HOLDERS OF ITS 9.25% SENIOR NOTES DUE 2014 AND ITS 10.5% SENIOR SUBORDINATED NOTES DUE 2016 AS WELL AS TO THE TRUSTEE FOR EACH SERIES OF NOTES PURSUANT TO SECTION 405 OF THE INDENTURE WITH RESPECT TO EACH SERIES OF NOTES. Form 8-K Sally Beauty Holdings, Inc. - SBH Filed: December 19, 2006 (period: December 19, 2006) Report of unscheduled material events or corporate changes.

2 Item 7.01 Regulation FD Disclosure Item 9.01 Financial Statements and Exhibits SIGNATURE EXHIBIT INDEX Table of Contents EX-99.1 (SCRIPTED QUESTIONS AND ANSWERS)

3 SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: December 19, 2006 (Date of earliest event reported) SALLY BEAUTY HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware (Commission file number) (State or other jurisdiction of incorporation) (I.R.S. Employer Identification Number) 3001 Colorado Boulevard Denton, Texas (Address of principal executive offices) (940) (Registrant s telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR ) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR e-4(c))

4 Item 7.01 Regulation FD Disclosure On December 19, 2006, Sally Beauty Holdings, Inc. (the Company ) announced that (1) its Beauty Systems Group LLC subsidiary, other than its Armstrong-McCall division ( BSG ), will not retain its rights to distribute the professional products of the Professional Products Division of L Oreal USA S/D, Inc. ( L Oreal ) through its distributor sales consultants (effective January 30, 2007, with exclusivity ending December 31, 2006) or in its stores on an exclusive basis (effective January 1, 2007) in those geographic areas within the U.S. in which BSG currently has distribution rights, and (2) BSG s Armstrong McCall division will not retain the rights to distribute Redken professional products through distributor sales consultants or its stores. In replacement of these rights, BSG entered into long-term agreements with L Oreal under which, as of January 1, 2007, BSG will have non-exclusive rights to distribute the same L Oreal professional products in its stores that it previously had exclusive rights to in its stores and through its sales consultants. Armstrong McCall will retain its exclusive rights to distribute Matrix products in its territories. Attached as Exhibit 99.1 are scripted Questions and Answers (Q&A), dated December 19, 2006, to be used by the Company when discussing these developments with representatives of the financial community. In accordance with General Instruction B.2 of Form 8-K, the information included or incorporated in Item 7.01 of this report, including Exhibit 99.1, is being furnished to the Commission and shall not be deemed filed for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act, except as shall be expressly set forth by specific reference in such filing. Item 9.01 Financial Statements and Exhibits (d) See exhibit index. 2

5 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Date: December 19, 2006 SALLY BEAUTY HOLDINGS, INC. By: /s/ Raal H. Roos Name: Raal H. Roos Title: Senior Vice President, General Counsel and Secretary 3

6 Exhibit Number EXHIBIT INDEX Description 99.1 Scripted Questions and Answers (Q&A), dated December 19, 2006, to be used by Sally Beauty Holdings, Inc. when discussing developments to its relationship with L Oreal with representatives of the financial community 4

7 Exhibit 99.1 Investor Q&A What did Sally Beauty Holdings, Inc. announce? On December 19, 2006, Sally Beauty Holdings, Inc. (the Company ) announced that (1) its Beauty Systems Group LLC subsidiary, other than its Armstrong-McCall division ( BSG ), will not retain its rights to distribute the professional products of the Professional Products Division of L Oreal USA S/D, Inc. ( L Oreal ) through its distributor sales consultants (effective January 30, 2007, with exclusivity ending December 31, 2006) or in its stores on an exclusive basis (effective January 1, 2007) in those geographic areas within the U.S. in which BSG currently has distribution rights, and (2) BSG s Armstrong McCall division will not retain the rights to distribute Redken professional products through distributor sales consultants or its stores. In replacement of these rights, BSG entered into long-term agreements with L Oreal under which, as of January 1, 2007, BSG will have non-exclusive rights to distribute the same L Oreal professional products in its stores that it previously had exclusive rights to in its stores and through its sales consultants. Armstrong McCall will retain its exclusive rights to distribute Matrix products in its territories. Are L Oreal products still going to be available in BSG/Sally Beauty Supply stores and through Armstrong McCall? Yes. L Oreal professional products will remain available in BSG stores that currently carry these products. Sally Beauty Supply stores, which carry a different selection of L Oreal products from those carried in BSG stores, are not impacted by these developments. Armstrong McCall will not retain the rights to distribute Redken professional products through its distributor sales consultants or its stores, but will retain its exclusive rights to distribute Matrix products in its territories. What are your next steps? BSG intends to begin marketing certain product lines that were previously unavailable through its outlets and also to expand existing product lines in new territories. BSG will be exploring ways to maximize the efficiency of its structure to mitigate the impact of these developments. BSG will encourage, through financial incentives, the retention of distributor sales consultants needed to effect the new business plan. BSG expects to shift a portion of its lost L Oreal distribution business into its BSG stores. BSG intends to continue expanding its business into underserved geographic areas, including Florida. What is the anticipated financial impact of these developments on your 2007 financials? We expect the impact of the loss of BSG s exclusive rights to distribute L Oreal professional products in BSG stores and by its distributor sales consultants to negatively impact our consolidated revenue by approximately $110 million during the last nine months of our 2007 fiscal year. This number includes anticipated ancillary impact on revenue from other products that may be indirectly affected by these developments. However, we expect to mitigate some of this impact through the actions described above.

8 Cautionary Language Concerning Forward-Looking Statements This Investor Q&A includes forward-looking statements within the meaning of the Private Securities Reform Act of All statements other than statements of historical information are forward-looking statements. Forward-looking statements are subject to known and unknown risks and uncertainties, many of which may be beyond the Company s control. A number of important factors could cause actual results to differ materially from those in the forward-looking statements. Factors that could cause actual results to differ from those in the forward-looking statements include: the effects of the substantial debt of the Company s subsidiaries; loss of the Company s subsidiaries distributorship rights; competition within relevant product markets; sales by unauthorized distributors in the Company s exclusive markets; dependence on certain suppliers of manufactured products and termination of distribution agreements with key suppliers that cover exclusive territories; the effect of consolidation in the beauty supply industry; the risk that the benefits from the Company s separation with Alberto-Culver Company may not be fully realized or may take longer to realize than expected; the impact of certain events on the tax-free treatment of the Company s separation; the Company s ability to maintain and/or improve sales and earnings performance; the Company s ability to attract and retain qualified personnel and key employees; risks inherent in acquisitions, dispositions and strategic alliances; foreign currency exchange and interest rate fluctuations; general economic, political and business conditions that would adversely affect the Company or its suppliers, distributors or customers; adverse weather conditions, natural disasters and acts of terrorism; changes in costs, including changes in labor costs, raw material prices or advertising and marketing expenses; the costs and effects of unanticipated legal or administrative proceedings; and disruption from the Company s separation with Alberto-Culver Company making it more difficult for the Company to maintain relationships with its customers, employees or suppliers. Forward-looking statements are made only as of the date of this Investor Q&A, and the Company does not undertake any obligation, other than as may be required by law, to update or revise any forward-looking statements to reflect changes in assumptions, the occurrence of unanticipated events, changes in future operating results over time or otherwise. Created by 10KWizard Sally Beauty Holding, 8-K, December 19, 2006

Learning Tree International, Inc.

Learning Tree International, Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

CURTISS WRIGHT CORP. FORM 8-K/A (Unscheduled Material Events) Filed 12/12/2002 For Period Ending 10/29/2002

CURTISS WRIGHT CORP. FORM 8-K/A (Unscheduled Material Events) Filed 12/12/2002 For Period Ending 10/29/2002 CURTISS WRIGHT CORP FORM 8-K/A (Unscheduled Material Events) Filed 12/12/2002 For Period Ending 10/29/2002 Address 1200 WALL ST W LYNDHURST, New Jersey 07071 Telephone 201-896-8400 CIK 0000026324 Industry

More information

SOUTHERN CO FORM 8-K. (Current report filing) Filed 01/02/15 for the Period Ending 01/02/15

SOUTHERN CO FORM 8-K. (Current report filing) Filed 01/02/15 for the Period Ending 01/02/15 SOUTHERN CO FORM 8-K (Current report filing) Filed 01/02/15 for the Period Ending 01/02/15 Address 30 IVAN ALLEN JR. BLVD., N.W. ATLANTA, GA 30308 Telephone 4045065000 CIK 0000092122 Symbol SO SIC Code

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION. Washington, D. C FORM 8-K CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION. Washington, D. C FORM 8-K CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest

More information

TETRA Technologies, Inc. (Exact name of registrant as specified in its charter)

TETRA Technologies, Inc. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (date of earliest event

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC FORM 8-K/A MICROCHIP TECHNOLOGY INCORPORATED

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC FORM 8-K/A MICROCHIP TECHNOLOGY INCORPORATED UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 June 8, 2016 (April 4, 2016) Date

More information

United States Securities and Exchange Commission Washington, D.C FORM SD SPECIALIZED DISCLOSURE REPORT

United States Securities and Exchange Commission Washington, D.C FORM SD SPECIALIZED DISCLOSURE REPORT United States Securities and Exchange Commission Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT HollyFrontier Corporation (Exact name of registrant as specified in its charter) Delaware 1-3876

More information

3M CO FORM 8-K. (Current report filing) Filed 07/23/03 for the Period Ending 07/21/03

3M CO FORM 8-K. (Current report filing) Filed 07/23/03 for the Period Ending 07/21/03 3M CO FORM 8-K (Current report filing) Filed 07/23/03 for the Period Ending 07/21/03 Address 3M CENTER BLDG. 220-11W-02 ST PAUL, MN 55144-1000 Telephone 6517332204 CIK 0000066740 Symbol MMM SIC Code 3841

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest

More information

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR )

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest

More information

FORM 8-K. DRONE AVIATION HOLDING CORP. (Exact name of registrant as specified in its charter)

FORM 8-K. DRONE AVIATION HOLDING CORP. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K Current Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

Mobiquity Technologies, Inc.

Mobiquity Technologies, Inc. SECURITIES & EXCHANGE COMMISSION EDGAR FILING Mobiquity Technologies, Inc. Form: 8-K Date Filed: 2012-03-13 Corporate Issuer CIK: 1084267 Symbol: MOBQ Fiscal Year End: 12/31 Copyright 2014, Issuer Direct

More information

Marchex, Inc. (Exact name of Registrant as Specified in its Charter)

Marchex, Inc. (Exact name of Registrant as Specified in its Charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event

More information

ALLIANCE DATA SYSTEMS CORPORATION (Exact Name of Registrant as Specified in Charter)

ALLIANCE DATA SYSTEMS CORPORATION (Exact Name of Registrant as Specified in Charter) SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported):

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM SD

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report AVERY DENNISON CORPORATION (Exact name of registrant as specified in its charter) Delaware

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event

More information

AMERICAN MIDSTREAM PARTNERS, LP (Exact name of registrant as specified in its charter)

AMERICAN MIDSTREAM PARTNERS, LP (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C Form SD SPECIALIZED DISCLOSURE REPORT. Tenneco Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C Form SD SPECIALIZED DISCLOSURE REPORT. Tenneco Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form SD SPECIALIZED DISCLOSURE REPORT Tenneco Inc. (Exact name of registrant as specified in its charter) Delaware 1-12387 76-0515284

More information

ADMA BIOLOGICS, INC. (Exact name of registrant as specified in its charter)

ADMA BIOLOGICS, INC. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

THIRD QUARTER SECURITIES AND EXCHANGE COMMISSION. Washington, DC FORM 10-Q

THIRD QUARTER SECURITIES AND EXCHANGE COMMISSION. Washington, DC FORM 10-Q THIRD ----- QUARTER ------- 2001 ---- SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For quarter ended

More information

Agios Pharmaceuticals, Inc. (Exact Name of Registrant as Specified in Charter)

Agios Pharmaceuticals, Inc. (Exact Name of Registrant as Specified in Charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

VONAGE HOLDINGS CORP.

VONAGE HOLDINGS CORP. UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C FORM8-K/A. AmendmentNo.1 CURRENTREPORT PursuanttoSection13or15(d)ofthe

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C FORM8-K/A. AmendmentNo.1 CURRENTREPORT PursuanttoSection13or15(d)ofthe UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM8-K/A AmendmentNo.1 CURRENTREPORT PursuanttoSection13or15(d)ofthe SecuritiesExchangeActof1934 DateofReport(Dateofearliestevent

More information

ADMA BIOLOGICS, INC. (Exact name of registrant as specified in its charter)

ADMA BIOLOGICS, INC. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

FORM 8-K. SUNSHINE BIOPHARMA, INC. (Exact name of small business issuer as specified in its charter)

FORM 8-K. SUNSHINE BIOPHARMA, INC. (Exact name of small business issuer as specified in its charter) U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported):

More information

ORGANOVO HOLDINGS, INC.

ORGANOVO HOLDINGS, INC. ORGANOVO HOLDINGS, INC. FORM 8-K (Current report filing) Filed 11/18/14 for the Period Ending 11/16/14 Address 6275 NANCY RIDGE DRIVE SUITE 110 SAN DIEGO, CA 92121 Telephone 858-550-9994 CIK 0001497253

More information

QUADRANT 4 SYSTEM CORP

QUADRANT 4 SYSTEM CORP QUADRANT 4 SYSTEM CORP FORM 8-K (Current report filing) Filed 05/08/14 for the Period Ending 05/05/14 Address 2850 GOLF ROAD, SUITE 405 ROLLING MEADOWS, IL 60008 Telephone 732-798-3000 CIK 0000878802 Symbol

More information

Mobiquity Technologies, Inc.

Mobiquity Technologies, Inc. SECURITIES & EXCHANGE COMMISSION EDGAR FILING Form: 8-K Date Filed: 2013-09-20 Corporate Issuer CIK: 1084267 Symbol: MOBQ Fiscal Year End: 12/31 Copyright 2014, Issuer Direct Corporation. All Right Reserved.

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM SD SPECIALIZED DISCLOSURE REPORT AVON PRODUCTS, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM SD SPECIALIZED DISCLOSURE REPORT AVON PRODUCTS, INC. AVP SD 5/26/2016 Section 1: SD (SD) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT AVON PRODUCTS, INC. (Exact name of registrant as specified

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM SD Specialized Disclosure Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM SD Specialized Disclosure Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report IPG PHOTONICS CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-33155

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 November 10, 2016 Date of Report (Date

More information

A. O. Smith Corporation

A. O. Smith Corporation UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form SD SPECIALIZED DISCLOSURE REPORT A. O. Smith Corporation (Exact Name of Registrant as Specified in Charter) Delaware 1-475 39-0619790

More information

UNITED STATES SECURITIES AN D EXCHANGE COMMISSION Washington, D.C FORM SD

UNITED STATES SECURITIES AN D EXCHANGE COMMISSION Washington, D.C FORM SD UNITED STATES SECURITIES AN D EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT VALEANT PHARMACEUTICALS INTERNATIONAL, INC. (Exact name of the registrant as specified in

More information

DOWDUPONT INC. (Exact name of registrant as specified in its charter)

DOWDUPONT INC. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C FORM 6-K PHOENIX NEW MEDIA LIMITED

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C FORM 6-K PHOENIX NEW MEDIA LIMITED UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 January 2018 Commission

More information

SECURITIES AND EXCHANGE COMMISSION FORM 8-K. Current report filing

SECURITIES AND EXCHANGE COMMISSION FORM 8-K. Current report filing SECURITIES AND EXCHANGE COMMISSION FORM 8-K Current report filing Filing Date: 2005-10-26 Period of Report: 2005-10-26 SEC Accession No. 0000914121-05-002006 (HTML Version on secdatabase.com) FILER AMERICAN

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 October 14, 2016 Date of Report (Date

More information

Akcea Therapeutics, Inc. (Exact name of registrant as specified in its charter)

Akcea Therapeutics, Inc. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

FORM 8-K. GARMIN LTD. (Exact name of registrant as specified in its charter)

FORM 8-K. GARMIN LTD. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported):

More information

FORM 8-K. MCORPCX, INC. (Exact name of registrant as specified in its charter)

FORM 8-K. MCORPCX, INC. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 1, 2017 ( February1,2017)

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K. Stamps.com Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K. Stamps.com Inc. OMB APPROVAL OMB Number: 3235-0060 Expires: May 31, 2000 Estimated average burden hours per response...5.00 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT

More information

Akcea Therapeutics, Inc. (Exact name of registrant as specified in its charter)

Akcea Therapeutics, Inc. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM SD SPECIALIZED DISCLOSURE REPORT HARRIS CORPORATION

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM SD SPECIALIZED DISCLOSURE REPORT HARRIS CORPORATION UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT HARRIS CORPORATION (Exact name of the registrant as specified in its charter) Delaware 1-3863

More information

STURM, RUGER & COMPANY, INC. (Exact Name of Registrant as Specified in its Charter)

STURM, RUGER & COMPANY, INC. (Exact Name of Registrant as Specified in its Charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report STURM, RUGER & COMPANY, INC. (Exact Name of Registrant as Specified in its Charter) DELAWARE

More information

MASTERCARD INC FORM 8-K. (Current report filing) Filed 11/13/02 for the Period Ending 11/13/02

MASTERCARD INC FORM 8-K. (Current report filing) Filed 11/13/02 for the Period Ending 11/13/02 MASTERCARD INC FORM 8-K (Current report filing) Filed 11/13/02 for the Period Ending 11/13/02 Address 2000 PURCHASE STREET PURCHASE, NY 10577 Telephone 9142492000 CIK 0001141391 Symbol MA SIC Code 7389

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

SORRENTO THERAPEUTICS, INC. (Exact Name of Registrant as Specified in its Charter)

SORRENTO THERAPEUTICS, INC. (Exact Name of Registrant as Specified in its Charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event

More information

FORM 8-K. DIAMEDICA THERAPEUTICS INC. (Exact name of registrant as specified in its charter)

FORM 8-K. DIAMEDICA THERAPEUTICS INC. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

FORM SD Specialized Disclosure Report

FORM SD Specialized Disclosure Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM SD Specialized Disclosure Report PLY GEM HOLDINGS, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35930

More information

SPHERIX INCORPORATED (Exact Name of Registrant as Specified in Charter)

SPHERIX INCORPORATED (Exact Name of Registrant as Specified in Charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

BANK ONE CORP /OH/ FORM 11-K (Annual Report of Employee Stock Plans) Filed 7/11/1997 For Period Ending 12/31/1996

BANK ONE CORP /OH/ FORM 11-K (Annual Report of Employee Stock Plans) Filed 7/11/1997 For Period Ending 12/31/1996 BANK ONE CORP /OH/ FORM 11-K (Annual Report of Employee Stock Plans) Filed 7/11/1997 For Period Ending 12/31/1996 Address 100 E BROAD ST COLUMBUS, Ohio 43271 Telephone 614-248-5944 CIK 0000036090 Fiscal

More information

WALGREEN CO FORM 8-K. (Current report filing) Filed 09/16/14 for the Period Ending 09/16/14

WALGREEN CO FORM 8-K. (Current report filing) Filed 09/16/14 for the Period Ending 09/16/14 WALGREEN CO FORM 8-K (Current report filing) Filed 09/16/14 for the Period Ending 09/16/14 Address 108 WILMOT RD DEERFIELD, IL 60015 Telephone 8479402500 CIK 0000104207 Symbol WAG SIC Code 5912 - Drug

More information

SORRENTO THERAPEUTICS, INC. (Exact name of registrant as specified in its charter)

SORRENTO THERAPEUTICS, INC. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

CURTISS WRIGHT CORP. FORM 8-K (Unscheduled Material Events) Filed 8/2/1999 For Period Ending 12/31/1999

CURTISS WRIGHT CORP. FORM 8-K (Unscheduled Material Events) Filed 8/2/1999 For Period Ending 12/31/1999 CURTISS WRIGHT CORP FORM 8-K (Unscheduled Material Events) Filed 8/2/1999 For Period Ending 12/31/1999 Address 1200 WALL ST W LYNDHURST, New Jersey 07071 Telephone 201-896-8400 CIK 0000026324 Industry

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM SD SPECIALIZED DISCLOSURE REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM SD SPECIALIZED DISCLOSURE REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT THERMO FISHER SCIENTIFIC INC. (Exact name of registrant as specified in its charter) Delaware

More information

Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form SD SPECIALIZED DISCLOSURE REPORT Bio-Rad Laboratories, Inc. (Exact Name of Registrant as Specified in Charter) DELAWARE 1-7928

More information

API Technologies Corp.

API Technologies Corp. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report API Technologies Corp. (Exact name of registrant as specified in its charter) Delaware 001-35214

More information

Arsanis, Inc. (Exact name of registrant as specified in its charter)

Arsanis, Inc. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

Mobiquity Technologies, Inc.

Mobiquity Technologies, Inc. SECURITIES & EXCHANGE COMMISSION EDGAR FILING Mobiquity Technologies, Inc. Form: 8-K Date Filed: 2011-10-03 Corporate Issuer CIK: 1084267 Symbol: MOBQ Fiscal Year End: 12/31 Copyright 2014, Issuer Direct

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 March 7, 2018 Date of Report (Date

More information

UTILICRAFT AEROSPACE INDUSTRIES, INC.

UTILICRAFT AEROSPACE INDUSTRIES, INC. UTILICRAFT AEROSPACE INDUSTRIES, INC. FORM 8-K (Current report filing) Filed 02/11/13 for the Period Ending 02/11/13 Address 401 RYLAND STREET, SUITE 200-A RENO, NV, 89502 Telephone 612-615-9334 CIK 0001334740

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event

More information

Galena Biopharma, Inc. (Exact name of registrant as specified in its charter)

Galena Biopharma, Inc. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

Magnetek, Inc. (Exact Name of Registrant as Specified in Charter)

Magnetek, Inc. (Exact Name of Registrant as Specified in Charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form SD SPECIALIZED DISCLOSURE REPORT Magnetek, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-10233 95-3917584

More information

IDEXX LABORATORIES, INC. (Exact name of registrant as specified in its charter)

IDEXX LABORATORIES, INC. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT IDEXX LABORATORIES, INC. (Exact name of registrant as specified in its charter) Delaware 000-19271

More information

FORM 8-K. JACK IN THE BOX INC. (Exact name of registrant as specified in its charter)

FORM 8-K. JACK IN THE BOX INC. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event

More information

STURM, RUGER & COMPANY, INC. (Exact Name of Registrant as Specified in its Charter)

STURM, RUGER & COMPANY, INC. (Exact Name of Registrant as Specified in its Charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

FORM SD Specialized Disclosure Report

FORM SD Specialized Disclosure Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report (Exact name of registrant as specified in its charter) Delaware 1-7724 39-0622040 (Commission

More information

ResMed Inc. (Exact Name of Registrant as Specified in Charter)

ResMed Inc. (Exact Name of Registrant as Specified in Charter) SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SD Specialized Disclosure Report ResMed Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-15317 98-0152841 (State or Other

More information

MAGNEGAS CORPORATION (Exact name of registrant as specified in its charter)

MAGNEGAS CORPORATION (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event

More information

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C FORM 10-Q

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C FORM 10-Q SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended SEPTEMBER 30,

More information

VistaGen Therapeutics, Inc. (Exact name of registrant as specified in its charter.)

VistaGen Therapeutics, Inc. (Exact name of registrant as specified in its charter.) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event

More information

MELLANOX TECHNOLOGIES, LTD. (Exact Name of Registrant as Specified in Its Charter)

MELLANOX TECHNOLOGIES, LTD. (Exact Name of Registrant as Specified in Its Charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT Commission File No. 001-33299 MELLANOX TECHNOLOGIES, LTD. (Exact Name of Registrant as Specified

More information

BEST BUY CO INC FORM SD. (Specialized Disclosure Report) Filed 06/01/15

BEST BUY CO INC FORM SD. (Specialized Disclosure Report) Filed 06/01/15 BEST BUY CO INC FORM SD (Specialized Disclosure Report) Filed 06/01/15 Address 7601 PENN AVE SOUTH RICHFIELD, MN 55423 Telephone 6122911000 CIK 0000764478 Symbol BBY SIC Code 5731 - Radio, Television,

More information

FORM SD Specialized Disclosure Report

FORM SD Specialized Disclosure Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM SD Specialized Disclosure Report (Exact name of registrant as specified in its charter) Delaware 001-07201 33-0379007 (State or

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C Form 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C Form 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C FORM SD SPECIALIZED DISCLOSURE REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C FORM SD SPECIALIZED DISCLOSURE REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT AMERICAN AXLE & MANUFACTURING HOLDINGS, INC. (Exact Name of Registrant as Specified in Its

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM SD SPECIALIZED DISCLOSURE REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM SD SPECIALIZED DISCLOSURE REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT THE TIMKEN COMPANY (Exact Name of Registrant as Specified in its Charter) Ohio (State or Other

More information

4 th Quarter Fiscal 2017 Results Conference Call August 30, 2017

4 th Quarter Fiscal 2017 Results Conference Call August 30, 2017 4 th Quarter Fiscal 2017 Results Conference Call August 30, 2017 Forward Looking Statements and Non GAAP Financial Measures Information This presentation contains forward looking statements. Other than

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C Form 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C Form 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month

More information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K CURRENT REPORT

SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K CURRENT REPORT SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported):

More information

GILDAN ACTIVEWEAR INC.

GILDAN ACTIVEWEAR INC. GILDAN ACTIVEWEAR INC. FORM SD (Specialized Disclosure Report) Filed 06/02/14 Telephone 5147352023 CIK 0001061894 Symbol GIL SIC Code 2300 - Apparel & Other Finishd Prods of Fabrics & Similar Matl Industry

More information

SMARTSTOP SELF STORAGE, INC. / EXTRA SPACE STORAGE INC. PROPOSED MERGER EMPLOYEE Q&A

SMARTSTOP SELF STORAGE, INC. / EXTRA SPACE STORAGE INC. PROPOSED MERGER EMPLOYEE Q&A SMARTSTOP SELF STORAGE, INC. / EXTRA SPACE STORAGE INC. PROPOSED MERGER EMPLOYEE Q&A 1. Why is SmartStop merging with Extra Space? SmartStop Self Storage, Inc. ( SmartStop ) and Extra Space Storage Inc.

More information

Morgan Stanley Conference. November 15, 2017

Morgan Stanley Conference. November 15, 2017 Morgan Stanley Conference November 15, 2017 1 Forward Looking Statements Certain statements in this release or presentation, other than purely historical information, including estimates, projections,

More information

POPULAR ABS INC MORTGAGE PASS- THROUGH CERTIFICATES SERIES

POPULAR ABS INC MORTGAGE PASS- THROUGH CERTIFICATES SERIES POPULAR ABS INC MORTGAGE PASS- THROUGH CERTIFICATES SERIES 2004-4 FORM 10-K (Annual Report) Filed 03/24/05 for the Period Ending 12/31/04 Address 103 SPRINGER BLDG 3411 SILVERSIDE ROAD WILMINGTON, DE,

More information

SECURITIES AND EXCHANGE COMMISSION

SECURITIES AND EXCHANGE COMMISSION SECURITIES AND EXCHANGE COMMISSION SEC FORM 17-C CURRENT REPORT UNDER SECTION 17 OF THE SECURITIES REGULATIONS CODE (SRC) AND SRC RULE 17(a)-1(b)(3) THEREUNDER 1. January 7, 2014 Date of Report (Date of

More information

LogMeIn, Inc. (Exact Name of Registrant as Specified in Charter)

LogMeIn, Inc. (Exact Name of Registrant as Specified in Charter) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date

More information

Schedule of Matters Reserved for the Board

Schedule of Matters Reserved for the Board Schedule of Matters Reserved for the Board Brambles Limited Instituted: 4 December 2006 Amended: 24 June 2009, 28 April 2011 and 1 July 2014 1. Board Responsibility 1.1 Management The Board is responsible

More information

SECURITIES & EXCHANGE COMMISSION EDGAR FILING MYMETICS CORP. Form: 8-K. Date Filed:

SECURITIES & EXCHANGE COMMISSION EDGAR FILING MYMETICS CORP. Form: 8-K. Date Filed: SECURITIES & EXCHANGE COMMISSION EDGAR FILING MYMETICS CORP Form: 8-K Date Filed: 2018-04-23 Corporate Issuer CIK: 927761 Copyright 2018, Issuer Direct Corporation. All Right Reserved. Distribution of

More information

SIGNET JEWELERS LIMITED (Exact name of registrant as specified in its charter)

SIGNET JEWELERS LIMITED (Exact name of registrant as specified in its charter) UNITEDSTATES SECURITIESANDEXCHANGECOMMISSION Washington,D.C.20549 FORM8-K CURRENTREPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported):

More information

NXP Semiconductors N.V. (Exact Name of the Registrant as Specified in its Charter)

NXP Semiconductors N.V. (Exact Name of the Registrant as Specified in its Charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form SD SPECIALIZED DISCLOSURE REPORT NXP Semiconductors N.V. (Exact Name of the Registrant as Specified in its Charter) The Netherlands

More information

CAPSTONE TURBINE CORPORATION

CAPSTONE TURBINE CORPORATION UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report CAPSTONE TURBINE CORPORATION (Exact name of registrant as specified in its charter) Delaware

More information

EXIDE TECHNOLOGIES CORPORATE GOVERNANCE GUIDELINES. As of February 5, 2018

EXIDE TECHNOLOGIES CORPORATE GOVERNANCE GUIDELINES. As of February 5, 2018 EXIDE TECHNOLOGIES CORPORATE GOVERNANCE GUIDELINES As of February 5, 2018 One of the most important corporate objectives of Exide Technologies (the Company ) is to engage in those business activities that

More information